Published in Cancer Lett on August 07, 2010
Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol (2012) 1.74
Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol (2013) 1.72
Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World J Gastroenterol (2014) 1.51
Oral bacteria and cancer. PLoS Pathog (2014) 1.05
Variations in Helicobacter pylori cytotoxin-associated genes and their influence in progression to gastric cancer: implications for prevention. PLoS One (2012) 0.92
H. pylori vaccines: why we still don't have any. Hum Vaccin (2011) 0.90
Using antimicrobial adjuvant therapy in cancer treatment: a review. Infect Agent Cancer (2012) 0.86
Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer. Sci Rep (2014) 0.85
Role of Helicobacter pylori infection in pathogenesis of gastric carcinoma. World J Gastrointest Pathophysiol (2016) 0.84
Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect Agent Cancer (2016) 0.83
Revealing the molecular mechanism of gastric cancer marker annexin A4 in cancer cell proliferation using exon arrays. PLoS One (2012) 0.83
Acetylation of drosha on the N-terminus inhibits its degradation by ubiquitination. PLoS One (2013) 0.81
A clinical perspective on the role of chronic inflammation in gastrointestinal cancer. Clin Exp Gastroenterol (2014) 0.81
bak deletion stimulates gastric epithelial proliferation and enhances Helicobacter felis-induced gastric atrophy and dysplasia in mice. Am J Physiol Gastrointest Liver Physiol (2015) 0.80
Serum biomarker panels for diagnosis of gastric cancer. Onco Targets Ther (2016) 0.80
Cyclooxygenase-2 polymorphisms and the risk of gastric cancer in various degrees of relationship in the Chinese Han population. Oncol Lett (2011) 0.79
Mobile elements and viral integrations prompt considerations for bacterial DNA integration as a novel carcinogen. Cancer Lett (2014) 0.79
Isolating, immunophenotyping and ex vivo stimulation of CD4+ and CD8+ gastric lymphocytes during murine Helicobacter pylori infection. J Immunol Methods (2012) 0.76
Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells. Cell Microbiol (2016) 0.76
Conifer Green Needle Complex in Patients with Precancerous Gastric Lesions: An Observational Pilot Study. Evid Based Complement Alternat Med (2016) 0.75
Distinguishing potential bacteria-tumor associations from contamination in a secondary data analysis of public cancer genome sequence data. Microbiome (2017) 0.75
Eradication of Helicobacter pylori Infection Restores ki67, p53, and Cyclin D1 Immunoreactivity in the Human Gastric Epithelium. Clin Med Insights Gastroenterol (2016) 0.75
Genome Sequence and Annotation of Helicobacter pylori Strain Hp238, Isolated from a Taiwanese Patient with Mucosa-Associated Lymphoid Tissue Lymphoma. Genome Announc (2015) 0.75
Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer. Infect Agent Cancer (2017) 0.75
The potential role of microbes in oncogenesis with particular emphasis on oral cancer. Saudi Med J (2016) 0.75
Treatment of synchronous adenocarcinoma and lymphoma of the stomach: A case report. Mol Clin Oncol (2016) 0.75
Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan. Gastric Cancer (2015) 0.75
The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors. Curr Gastroenterol Rep (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature (1997) 34.00
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature (1999) 19.34
Helicobacter pylori infection. N Engl J Med (2002) 14.81
The global health burden of infection-associated cancers in the year 2002. Int J Cancer (2006) 13.57
Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92
Helicobacter pylori infection and gastric lymphoma. N Engl J Med (1994) 10.26
Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer (2002) 10.19
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
The primary transcriptome of the major human pathogen Helicobacter pylori. Nature (2010) 7.70
Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol (2004) 7.22
Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem (1992) 6.54
Gastric cancer originating from bone marrow-derived cells. Science (2004) 6.04
Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology (1998) 5.15
The versatile bacterial type IV secretion systems. Nat Rev Microbiol (2003) 4.98
Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut (2001) 4.97
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology (2003) 4.52
Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell (2008) 4.43
Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc Natl Acad Sci U S A (2001) 4.05
A model for gastric cancer epidemiology. Lancet (1975) 4.02
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol (2009) 3.88
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med (2007) 3.70
A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology (2007) 3.54
Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38
Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol (1998) 3.31
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest (2009) 3.26
Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology (2008) 3.25
Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci U S A (2008) 3.17
Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med (2009) 3.12
The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. Proc Natl Acad Sci U S A (2006) 3.07
miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest (2008) 2.87
Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology (2008) 2.63
Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature (2007) 2.48
Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe (2007) 2.41
Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol (2008) 2.18
Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol (2009) 2.09
Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res (2008) 2.08
The complete genome sequence of Helicobacter pylori strain G27. J Bacteriol (2008) 2.05
Peptidoglycan crosslinking relaxation promotes Helicobacter pylori's helical shape and stomach colonization. Cell (2010) 2.02
Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori. Gastroenterology (2007) 1.98
Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology (2003) 1.96
Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis (2009) 1.89
Mechanisms of disease: Inflammation and the origins of cancer. Nat Clin Pract Oncol (2005) 1.88
Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res (2010) 1.80
Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res (2005) 1.74
NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J Clin Invest (2010) 1.64
L-arginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori. Infect Immun (2007) 1.54
Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol Med Microbiol (2007) 1.49
MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer (2010) 1.44
Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer. BMC Genomics (2009) 1.42
Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology (2005) 1.39
Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner. PLoS One (2010) 1.35
Helicobacter pylori is invasive and it may be a facultative intracellular organism. Cell Microbiol (2007) 1.33
Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res (2009) 1.33
Interaction of Helicobacter pylori with gastric epithelial cells is mediated by the p53 protein family. Gastroenterology (2008) 1.33
Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect Immun (2007) 1.32
EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J Biol Chem (2005) 1.27
A review of the genomics of gastric cancer. Clin Gastroenterol Hepatol (2006) 1.26
Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut (2006) 1.26
Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo. Gut (2006) 1.25
Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis. Clin Cancer Res (2008) 1.22
Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology (2003) 1.21
vacA i-region subtyping. Gastroenterology (2008) 1.18
From array-based hybridization of Helicobacter pylori isolates to the complete genome sequence of an isolate associated with MALT lymphoma. BMC Genomics (2010) 1.16
Conditional loss of TGF-beta signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Aliment Pharmacol Ther (2002) 1.15
Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest (2008) 1.14
Helicobacter pylori typing as a tool for tracking human migration. Clin Microbiol Infect (2009) 1.12
Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1). Infect Immun (2000) 1.06
In vivo disruption of the fas pathway abrogates gastric growth alterations secondary to Helicobacter infection. J Infect Dis (2000) 1.04
Helicobacter pylori and gastric cancer: possible role of microRNAs in this intimate relationship. Clin Microbiol Infect (2009) 1.04
Helicobacter-based mouse models of digestive system carcinogenesis. Methods Mol Biol (2009) 1.04
Acetylation of apurinic/apyrimidinic endonuclease-1 regulates Helicobacter pylori-mediated gastric epithelial cell apoptosis. Gastroenterology (2009) 1.02
CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection. Gastroenterology (2010) 1.02
Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication. J Gastroenterol (2009) 1.01
Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut (2006) 1.00
Diet synergistically affects helicobacter pylori-induced gastric carcinogenesis in nonhuman primates. Gastroenterology (2009) 1.00
A systematic review of meta-analyses on gene polymorphisms and gastric cancer risk. Curr Genomics (2008) 0.97
p27kip1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice. Gastroenterology (2005) 0.95
Helicobacter pylori in ectopic gastric mucosa in Meckel's diverticulum. Pathology (1998) 0.93
The somatostatin-gastrin link of Helicobacter pylori infection. Ann Med (1995) 0.91
Long-term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue transgenic mice. J Pathol (2003) 0.89
Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth. Dig Liver Dis (2001) 0.87
Effects of H. pylori infection of gastric epithelial cells on cell cycle control. Front Biosci (2001) 0.86
Helicobacter pylori regulates p21(WAF1) by histone H4 acetylation. Biochem Biophys Res Commun (2008) 0.86
Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am (2009) 0.84
Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol (2008) 7.65
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol (2010) 2.56
Chromogranin A--biological function and clinical utility in neuro endocrine tumor disease. Ann Surg Oncol (2010) 2.21
Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res (2004) 1.74
Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst (2008) 1.71
Engineering mucosal RNA interference in vivo. Mol Ther (2006) 1.43
Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol (2005) 1.36
Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett (2008) 1.29
Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev (2002) 1.29
Intentional swallowing of foreign bodies is a recurrent and costly problem that rarely causes endoscopy complications. Clin Gastroenterol Hepatol (2010) 1.09
Clinical significance of colonoscopic findings associated with colonic thickening on computed tomography: is colonoscopy warranted when thickening is detected? J Clin Gastroenterol (2008) 1.07
Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management. Med J Aust (2010) 1.02
Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells. Cancer Res (2003) 1.01
Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue. Clin Cancer Res (2008) 0.99
p27kip1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice. Gastroenterology (2005) 0.95
Expression of bile acid receptor TGR5 in gastric adenocarcinoma. Am J Physiol Gastrointest Liver Physiol (2012) 0.93
Obesity and related risk factors in gastric cardia adenocarcinoma. Gastric Cancer (2014) 0.92
Identification of genome-derived vaccine candidates conserved between human and mouse-adapted strains of H. pylori. Hum Vaccin (2010) 0.91
Positive serology for Helicobacter pylori and vomiting in the pregnancy. Arch Gynecol Obstet (2003) 0.91
Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis. Mod Pathol (2006) 0.90
H. pylori vaccines: why we still don't have any. Hum Vaccin (2011) 0.90
The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant. Langenbecks Arch Surg (2011) 0.89
Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori. J Gastroenterol Hepatol (2006) 0.87
Moving Helicobacter pylori vaccine development forward with bioinformatics and immunomics. Expert Rev Vaccines (2012) 0.87
Helicobacter pylori infection and the development of gastric cancer. N Engl J Med (2002) 0.85
Effect of proton pump inhibitors on the continuous real time (13)C-urea breath test. Am J Gastroenterol (2003) 0.85
Inflammation, immunity, vaccines for Helicobacter pylori infection. Helicobacter (2013) 0.82
Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection. Curr Treat Options Gastroenterol (2014) 0.82
Acetylation of drosha on the N-terminus inhibits its degradation by ubiquitination. PLoS One (2013) 0.81
Rodent models of Helicobacter infection, inflammation, and disease. Methods Mol Biol (2012) 0.81
Symptom evaluation in gastroesophageal reflux disease. J Clin Gastroenterol (2008) 0.80
Regulation of RKIP function by Helicobacter pylori in gastric cancer. PLoS One (2012) 0.80
Non-erosive reflux disease--defining the entity and delineating the management. Digestion (2008) 0.80
Helicobacter pylori and apoptosis. Methods Enzymol (2002) 0.79
Helicobacter pylori decreases p27 expression through the delta opioid receptor-mediated inhibition of histone acetylation within the p27 promoter. Cancer Lett (2012) 0.79
Targeting Helicobacter pylori in gastric carcinogenesis. Expert Opin Ther Targets (2007) 0.79
COX-2 inhibition and the prevention of gastric cancer. Digestion (2007) 0.78
Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model. Cancer Lett (2015) 0.78
Gastroesophageal reflux disease: then and now. J Clin Gastroenterol (2004) 0.78
p16Ink4a is overexpressed in H. pylori-associated gastritis and is correlated with increased epithelial apoptosis. Helicobacter (2003) 0.78
Will H. pylori stagger under the weight of this LOAD? A novel but expensive eradication regimen. Am J Gastroenterol (2011) 0.77
Whistler summary: "the slow rate of rapid progress". J Clin Gastroenterol (2007) 0.77
Clinical challenges and images in GI. Downhill esophageal varices secondary to superior vena cava occlusion. Gastroenterology (2008) 0.77
Isolating, immunophenotyping and ex vivo stimulation of CD4+ and CD8+ gastric lymphocytes during murine Helicobacter pylori infection. J Immunol Methods (2012) 0.76
Low utility of endoscopy for suspected upper gastrointestinal bleeding occurring in hospitalized patients. South Med J (2005) 0.76
The rediscovery of H. pylori bacteria in the gastric mucosa by Robin Warren, and implications of this finding for human biology and disease. Dig Dis Sci (2013) 0.76
A rare cause of constipation: obstructing small cell neuroendocrine carcinoma of the anal canal. Int J Colorectal Dis (2015) 0.75
p27kip1 expression is inversely related to the grade of gastric MALT lymphoma. Int J Gastrointest Cancer (2005) 0.75